Table 1 Population characteristics.

From: A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer

Training set

Validation set

Early gastric cancer (n = 9)

Early gastric cancer (n = 18)

 Men

8 (88.9)

 Men

16 (88.9)

 Age

72.8 ± 7.14

 Age

60.9 ± 11.6

 Histology

 Histology

  WD

5 (55.6)

  WD

6 (33.3)

  MD

3 (33.3)

  MD

6 (33.3)

  PD

0

  PD

1 (5.56)

  SR

1 (11.1)

  SR

5 (27.8)

 Stage

 Stage

  cT1aN0

5 (55.6)

  cT1aN0

7 (38.9)

  cT1bN0

3 (33.3)

  cT1bN0

11 (61.1)

Advanced gastric cancer (n = 2)

Advanced gastric cancer (n = 5)

 Men

2 (100)

 Men

3 (60)

 Age

74.5 ± 0.707

 Age

58.8 ± 5.63

 Histology

 Histology

  WD

0

  WD

0

  MD

1 (50)

  MD

2 (40)

  PD

1 (50)

  PD

1 (20)

  SR

0

  SR

2 (40)

 Stage

 Stage

  cT2N0

2 (100)

  cT2N0

2 (40)

  cT3N0

3 (60)

Control (n = 10)

Control (n = 20)

 Men

5 (50)

 Men

9 (45)

 Age

47.5 ± 8.53

 Age

44.2 ± 10.8

  1. Values are presented in number (%) or mean ± standard deviation.
  2. WD well-differentiated tubular adenocarcinoma, MD moderately differentiated tubular adenocarcinoma, PD poorly differentiated tubular adenocarcinoma, SR poorly cohesive carcinoma with signet ring cells.